Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Plasma-Lyte P is a sterile, nonpyrogenic isotonic solution designed for intravenous administration. It functions as a source of water and electrolytes, and is capable of inducing diuresis depending on the patient's clinical condition. The solution produces a metabolic alkalinizing effect, primarily due to the metabolism of its acetate and gluconate ions into carbon dioxide and water, a process that consumes hydrogen cations. It is indicated for fluid replacement in various conditions such as burns, head injury, fractures, infection, peritoneal irritation, and as intraoperative fluid replacement. It is also used in hemorrhagic shock and clinical situations requiring rapid blood transfusions, as well as in mild to moderate metabolic acidosis. The product is manufactured by Baxter Healthcare.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Plasma-Lyte P.